Preoperative frailty affects postoperative complications, exercise capacity, and home discharge rates after surgical and transcatheter aortic valve replacement

Assessment of frailty is important for risk stratification among the elderly with severe aortic stenosis (AS) when considering interventions such as surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). However, evidence of the impact of preoperative frailty on s...

Full description

Saved in:
Bibliographic Details
Published inHeart and vessels Vol. 36; no. 8; pp. 1234 - 1245
Main Authors Komaki, Kodai, Yoshida, Naofumi, Satomi-Kobayashi, Seimi, Tsuboi, Yasunori, Ogawa, Masato, Wakida, Kumiko, Toba, Takayoshi, Kawamori, Hiroyuki, Otake, Hiromasa, Omura, Atsushi, Yamanaka, Katsuhiro, Inoue, Takeshi, Yamashita, Tomoya, Sakai, Yoshitada, Izawa, Kazuhiro P., Okada, Kenji, Hirata, Ken-ichi
Format Journal Article
LanguageEnglish
Published Tokyo Springer Japan 01.08.2021
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0910-8327
1615-2573
1615-2573
DOI10.1007/s00380-021-01793-3

Cover

Loading…
Abstract Assessment of frailty is important for risk stratification among the elderly with severe aortic stenosis (AS) when considering interventions such as surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). However, evidence of the impact of preoperative frailty on short-term postoperative outcomes or functional recovery is limited. This retrospective study included 234 consecutive patients with severe AS who underwent SAVR or TAVR at Kobe University Hospital between Dec 2013 and Dec 2019. Primary outcomes were postoperative complications, postoperative 6-min walking distance (6MWD), and home discharge rates. The mean age was 82 ± 6.6 years. There were 169 (SAVR: 80, TAVR: 89) and 65 (SAVR: 20, TAVR: 45) patients in the non-frail and frail groups, respectively ( p  = 0.02). The postoperative complication rates in the frail group were significantly higher than those in the non-frail group [30.8% (SAVR: 35.0%, TAVR: 28.9%) vs. 10.7% (SAVR: 15.0%, TAVR: 6.7%), p  < 0.001]. The home discharge rate in the non-frail group was significantly higher than that in the frail group [85.2% (SAVR: 81.2%, TAVR: 88.8%) vs. 49.2% (SAVR: 55.0%, TAVR: 46.7%), p  < 0.001]. The postoperative 6MWD in the non-frail group was significantly longer than that in the frail group [299.3 ± 87.8 m (SAVR: 321.9 ± 90.8 m, TAVR: 281.1 ± 81.3 m) vs. 141.9 ± 92.4 m (SAVR: 167.8 ± 92.5 m, TAVR: 131.6 ± 91.3 m), p  < 0.001]. The TAVR group did not show a decrease in the 6MWD after intervention, regardless of frailty. We report for the first time that preoperative frailty was strongly associated with postoperative complications, 6MWD, and home discharge rates following both SAVR and TAVR. Preoperative frailty assessment may provide useful indications for planning better individualized therapeutic interventions and supporting comprehensive intensive care before and after interventions.
AbstractList Assessment of frailty is important for risk stratification among the elderly with severe aortic stenosis (AS) when considering interventions such as surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). However, evidence of the impact of preoperative frailty on short-term postoperative outcomes or functional recovery is limited. This retrospective study included 234 consecutive patients with severe AS who underwent SAVR or TAVR at Kobe University Hospital between Dec 2013 and Dec 2019. Primary outcomes were postoperative complications, postoperative 6-min walking distance (6MWD), and home discharge rates. The mean age was 82 ± 6.6 years. There were 169 (SAVR: 80, TAVR: 89) and 65 (SAVR: 20, TAVR: 45) patients in the non-frail and frail groups, respectively (p = 0.02). The postoperative complication rates in the frail group were significantly higher than those in the non-frail group [30.8% (SAVR: 35.0%, TAVR: 28.9%) vs. 10.7% (SAVR: 15.0%, TAVR: 6.7%), p < 0.001]. The home discharge rate in the non-frail group was significantly higher than that in the frail group [85.2% (SAVR: 81.2%, TAVR: 88.8%) vs. 49.2% (SAVR: 55.0%, TAVR: 46.7%), p < 0.001]. The postoperative 6MWD in the non-frail group was significantly longer than that in the frail group [299.3 ± 87.8 m (SAVR: 321.9 ± 90.8 m, TAVR: 281.1 ± 81.3 m) vs. 141.9 ± 92.4 m (SAVR: 167.8 ± 92.5 m, TAVR: 131.6 ± 91.3 m), p < 0.001]. The TAVR group did not show a decrease in the 6MWD after intervention, regardless of frailty. We report for the first time that preoperative frailty was strongly associated with postoperative complications, 6MWD, and home discharge rates following both SAVR and TAVR. Preoperative frailty assessment may provide useful indications for planning better individualized therapeutic interventions and supporting comprehensive intensive care before and after interventions.
Assessment of frailty is important for risk stratification among the elderly with severe aortic stenosis (AS) when considering interventions such as surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). However, evidence of the impact of preoperative frailty on short-term postoperative outcomes or functional recovery is limited. This retrospective study included 234 consecutive patients with severe AS who underwent SAVR or TAVR at Kobe University Hospital between Dec 2013 and Dec 2019. Primary outcomes were postoperative complications, postoperative 6-min walking distance (6MWD), and home discharge rates. The mean age was 82 ± 6.6 years. There were 169 (SAVR: 80, TAVR: 89) and 65 (SAVR: 20, TAVR: 45) patients in the non-frail and frail groups, respectively ( p  = 0.02). The postoperative complication rates in the frail group were significantly higher than those in the non-frail group [30.8% (SAVR: 35.0%, TAVR: 28.9%) vs. 10.7% (SAVR: 15.0%, TAVR: 6.7%), p  < 0.001]. The home discharge rate in the non-frail group was significantly higher than that in the frail group [85.2% (SAVR: 81.2%, TAVR: 88.8%) vs. 49.2% (SAVR: 55.0%, TAVR: 46.7%), p  < 0.001]. The postoperative 6MWD in the non-frail group was significantly longer than that in the frail group [299.3 ± 87.8 m (SAVR: 321.9 ± 90.8 m, TAVR: 281.1 ± 81.3 m) vs. 141.9 ± 92.4 m (SAVR: 167.8 ± 92.5 m, TAVR: 131.6 ± 91.3 m), p  < 0.001]. The TAVR group did not show a decrease in the 6MWD after intervention, regardless of frailty. We report for the first time that preoperative frailty was strongly associated with postoperative complications, 6MWD, and home discharge rates following both SAVR and TAVR. Preoperative frailty assessment may provide useful indications for planning better individualized therapeutic interventions and supporting comprehensive intensive care before and after interventions.
Assessment of frailty is important for risk stratification among the elderly with severe aortic stenosis (AS) when considering interventions such as surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). However, evidence of the impact of preoperative frailty on short-term postoperative outcomes or functional recovery is limited. This retrospective study included 234 consecutive patients with severe AS who underwent SAVR or TAVR at Kobe University Hospital between Dec 2013 and Dec 2019. Primary outcomes were postoperative complications, postoperative 6-min walking distance (6MWD), and home discharge rates. The mean age was 82 ± 6.6 years. There were 169 (SAVR: 80, TAVR: 89) and 65 (SAVR: 20, TAVR: 45) patients in the non-frail and frail groups, respectively (p = 0.02). The postoperative complication rates in the frail group were significantly higher than those in the non-frail group [30.8% (SAVR: 35.0%, TAVR: 28.9%) vs. 10.7% (SAVR: 15.0%, TAVR: 6.7%), p < 0.001]. The home discharge rate in the non-frail group was significantly higher than that in the frail group [85.2% (SAVR: 81.2%, TAVR: 88.8%) vs. 49.2% (SAVR: 55.0%, TAVR: 46.7%), p < 0.001]. The postoperative 6MWD in the non-frail group was significantly longer than that in the frail group [299.3 ± 87.8 m (SAVR: 321.9 ± 90.8 m, TAVR: 281.1 ± 81.3 m) vs. 141.9 ± 92.4 m (SAVR: 167.8 ± 92.5 m, TAVR: 131.6 ± 91.3 m), p < 0.001]. The TAVR group did not show a decrease in the 6MWD after intervention, regardless of frailty. We report for the first time that preoperative frailty was strongly associated with postoperative complications, 6MWD, and home discharge rates following both SAVR and TAVR. Preoperative frailty assessment may provide useful indications for planning better individualized therapeutic interventions and supporting comprehensive intensive care before and after interventions.Assessment of frailty is important for risk stratification among the elderly with severe aortic stenosis (AS) when considering interventions such as surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). However, evidence of the impact of preoperative frailty on short-term postoperative outcomes or functional recovery is limited. This retrospective study included 234 consecutive patients with severe AS who underwent SAVR or TAVR at Kobe University Hospital between Dec 2013 and Dec 2019. Primary outcomes were postoperative complications, postoperative 6-min walking distance (6MWD), and home discharge rates. The mean age was 82 ± 6.6 years. There were 169 (SAVR: 80, TAVR: 89) and 65 (SAVR: 20, TAVR: 45) patients in the non-frail and frail groups, respectively (p = 0.02). The postoperative complication rates in the frail group were significantly higher than those in the non-frail group [30.8% (SAVR: 35.0%, TAVR: 28.9%) vs. 10.7% (SAVR: 15.0%, TAVR: 6.7%), p < 0.001]. The home discharge rate in the non-frail group was significantly higher than that in the frail group [85.2% (SAVR: 81.2%, TAVR: 88.8%) vs. 49.2% (SAVR: 55.0%, TAVR: 46.7%), p < 0.001]. The postoperative 6MWD in the non-frail group was significantly longer than that in the frail group [299.3 ± 87.8 m (SAVR: 321.9 ± 90.8 m, TAVR: 281.1 ± 81.3 m) vs. 141.9 ± 92.4 m (SAVR: 167.8 ± 92.5 m, TAVR: 131.6 ± 91.3 m), p < 0.001]. The TAVR group did not show a decrease in the 6MWD after intervention, regardless of frailty. We report for the first time that preoperative frailty was strongly associated with postoperative complications, 6MWD, and home discharge rates following both SAVR and TAVR. Preoperative frailty assessment may provide useful indications for planning better individualized therapeutic interventions and supporting comprehensive intensive care before and after interventions.
Assessment of frailty is important for risk stratification among the elderly with severe aortic stenosis (AS) when considering interventions such as surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). However, evidence of the impact of preoperative frailty on short-term postoperative outcomes or functional recovery is limited. This retrospective study included 234 consecutive patients with severe AS who underwent SAVR or TAVR at Kobe University Hospital between Dec 2013 and Dec 2019. Primary outcomes were postoperative complications, postoperative 6-min walking distance (6MWD), and home discharge rates. The mean age was 82 ± 6.6 years. There were 169 (SAVR: 80, TAVR: 89) and 65 (SAVR: 20, TAVR: 45) patients in the non-frail and frail groups, respectively (p = 0.02). The postoperative complication rates in the frail group were significantly higher than those in the non-frail group [30.8% (SAVR: 35.0%, TAVR: 28.9%) vs. 10.7% (SAVR: 15.0%, TAVR: 6.7%), p < 0.001]. The home discharge rate in the non-frail group was significantly higher than that in the frail group [85.2% (SAVR: 81.2%, TAVR: 88.8%) vs. 49.2% (SAVR: 55.0%, TAVR: 46.7%), p < 0.001]. The postoperative 6MWD in the non-frail group was significantly longer than that in the frail group [299.3 ± 87.8 m (SAVR: 321.9 ± 90.8 m, TAVR: 281.1 ± 81.3 m) vs. 141.9 ± 92.4 m (SAVR: 167.8 ± 92.5 m, TAVR: 131.6 ± 91.3 m), p < 0.001]. The TAVR group did not show a decrease in the 6MWD after intervention, regardless of frailty. We report for the first time that preoperative frailty was strongly associated with postoperative complications, 6MWD, and home discharge rates following both SAVR and TAVR. Preoperative frailty assessment may provide useful indications for planning better individualized therapeutic interventions and supporting comprehensive intensive care before and after interventions.
Author Inoue, Takeshi
Kawamori, Hiroyuki
Yoshida, Naofumi
Satomi-Kobayashi, Seimi
Tsuboi, Yasunori
Wakida, Kumiko
Yamanaka, Katsuhiro
Ogawa, Masato
Yamashita, Tomoya
Komaki, Kodai
Toba, Takayoshi
Hirata, Ken-ichi
Otake, Hiromasa
Omura, Atsushi
Okada, Kenji
Izawa, Kazuhiro P.
Sakai, Yoshitada
Author_xml – sequence: 1
  givenname: Kodai
  surname: Komaki
  fullname: Komaki, Kodai
  organization: Division of Rehabilitation Medicine, Kobe University Hospital
– sequence: 2
  givenname: Naofumi
  surname: Yoshida
  fullname: Yoshida, Naofumi
  organization: Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine
– sequence: 3
  givenname: Seimi
  surname: Satomi-Kobayashi
  fullname: Satomi-Kobayashi, Seimi
  email: seimik@med.kobe-u.ac.jp
  organization: Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine
– sequence: 4
  givenname: Yasunori
  surname: Tsuboi
  fullname: Tsuboi, Yasunori
  organization: Division of Rehabilitation Medicine, Kobe University Hospital
– sequence: 5
  givenname: Masato
  surname: Ogawa
  fullname: Ogawa, Masato
  organization: Division of Rehabilitation Medicine, Kobe University Hospital, Department of Public Health, Kobe University Graduate School of Health Sciences
– sequence: 6
  givenname: Kumiko
  surname: Wakida
  fullname: Wakida, Kumiko
  organization: Department of Nutrition, Kobe University Hospital
– sequence: 7
  givenname: Takayoshi
  surname: Toba
  fullname: Toba, Takayoshi
  organization: Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine
– sequence: 8
  givenname: Hiroyuki
  surname: Kawamori
  fullname: Kawamori, Hiroyuki
  organization: Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine
– sequence: 9
  givenname: Hiromasa
  surname: Otake
  fullname: Otake, Hiromasa
  organization: Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine
– sequence: 10
  givenname: Atsushi
  surname: Omura
  fullname: Omura, Atsushi
  organization: Division of Cardiovascular Surgery, Department of Surgery, Kobe University Graduate School of Medicine
– sequence: 11
  givenname: Katsuhiro
  surname: Yamanaka
  fullname: Yamanaka, Katsuhiro
  organization: Division of Cardiovascular Surgery, Department of Surgery, Kobe University Graduate School of Medicine
– sequence: 12
  givenname: Takeshi
  surname: Inoue
  fullname: Inoue, Takeshi
  organization: Division of Cardiovascular Surgery, Department of Surgery, Kobe University Graduate School of Medicine
– sequence: 13
  givenname: Tomoya
  surname: Yamashita
  fullname: Yamashita, Tomoya
  organization: Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine
– sequence: 14
  givenname: Yoshitada
  surname: Sakai
  fullname: Sakai, Yoshitada
  organization: Division of Rehabilitation Medicine, Kobe University Graduate School of Medicine
– sequence: 15
  givenname: Kazuhiro P.
  surname: Izawa
  fullname: Izawa, Kazuhiro P.
  organization: Department of Public Health, Kobe University Graduate School of Health Sciences
– sequence: 16
  givenname: Kenji
  surname: Okada
  fullname: Okada, Kenji
  organization: Division of Cardiovascular Surgery, Department of Surgery, Kobe University Graduate School of Medicine
– sequence: 17
  givenname: Ken-ichi
  surname: Hirata
  fullname: Hirata, Ken-ichi
  organization: Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33615425$$D View this record in MEDLINE/PubMed
BookMark eNp9UsFu1DAQtVAR3S78AAcUiQuHBsZ2EtsXpKpqAakSHOBseZ3JbqrEDrazYr-GX8W721LooSfLM--9Gfu9M3LivENCXlN4TwHEhwjAJZTAaAlUKF7yZ2RBG1qXrBb8hCxAUSglZ-KUnMV4C0BrRdULcsp5RlWsXpDf3wL6CYNJ_RaLLph-SLvCdB3aFIvJx_TQtX6cht7mi3fxvMBfGGwfc91MxvZpd14Y1xYbP2LR9tFuTFhjkbkYs2DCUMQ5rDN_OOBSMC5msQ3uW8aH1Ntia4Y8KOA0GIsjuvSSPO_MEPHV3bkkP66vvl9-Lm--fvpyeXFT2gZkKnkruFyJBhioSrSqFbapDa6g4apSEiRVTNlcZpbJTljB2o4awbFTTBha8SX5eNSd5tWIrc2jgxn0FPrRhJ32ptf_d1y_0Wu_1UIqUdM6C7y7Ewj-54wx6TH_AQ6DcejnqFmlGJOg6j307SPorZ-Dy8_TrK6k4sAryKg3_270d5V77zJAHgE2-BgDdjqbcDAn7W3UFPQ-JvoYE51jog8xyQpLwh5R79WfJPEjKWawW2N4WPsJ1h8PbtNz
CitedBy_id crossref_primary_10_1007_s00380_022_02143_7
crossref_primary_10_3389_fcvm_2023_1164104
crossref_primary_10_1016_j_amjcard_2024_04_001
crossref_primary_10_1253_circrep_CR_24_0020
crossref_primary_10_3390_jcdd10040142
crossref_primary_10_1016_j_arr_2024_102266
crossref_primary_10_1111_jgs_18454
crossref_primary_10_1016_j_urolonc_2023_07_003
crossref_primary_10_2169_internalmedicine_3146_23
Cites_doi 10.1016/j.ijcard.2012.09.079
10.1161/CIR.0000000000000503
10.1111/j.1751-7133.2010.00151.x
10.1056/NEJMoa1008232
10.1093/ehjqcco/qcw001
10.1016/j.athoracsur.2018.03.003
10.1186/s12933-017-0577-8
10.1093/ejcts/ezs043
10.1177/2047487316679527
10.1371/journal.pone.0190359
10.1161/CIRCULATIONAHA.113.007477
10.1080/14017431.2019.1644366
10.1016/S0195-668X(03)00201-X
10.1016/j.cjca.2018.11.035
10.5551/jat.19737
10.1016/j.jtcvs.2019.11.069
10.1093/eurheartj/ehx391
10.2459/JCM.0000000000000494
10.1186/cc5713
10.1016/j.ahj.2016.12.005
10.1177/2047487313494029
10.1016/j.jacc.2016.12.006
10.1136/bmjopen-2018-024163
10.1002/ccd.27083
10.1056/NEJMoa1514616
10.1186/s13019-017-0655-8
10.4103/rcm.rcm_22_17
10.1038/nrdp.2016.6
10.1016/j.jacc.2017.06.024
10.1016/j.amjcard.2016.03.044
10.1016/j.athoracsur.2018.03.002
10.1016/j.ijcard.2014.03.121
10.1001/jamanetworkopen.2019.8398
10.1093/gerona/56.3.M146
10.1155/2018/9849475
10.1111/j.1076-7460.2007.06457.x
10.1002/ehf2.12052
10.1016/j.ajic.2004.10.008
ContentType Journal Article
Copyright Springer Japan KK, part of Springer Nature 2021
Copyright Springer Nature B.V. 2021
Copyright_xml – notice: Springer Japan KK, part of Springer Nature 2021
– notice: Copyright Springer Nature B.V. 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QO
8FD
FR3
K9.
NAPCQ
P64
7X8
5PM
DOI 10.1007/s00380-021-01793-3
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)

MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1615-2573
EndPage 1245
ExternalDocumentID PMC7897515
33615425
10_1007_s00380_021_01793_3
Genre Journal Article
GroupedDBID ---
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
1N0
1SB
203
28-
29I
29~
2J2
2JN
2JY
2KG
2LR
2P1
2VQ
2~H
30V
36B
3O-
4.4
406
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67Z
6NX
7X7
88E
8AO
8FI
8FJ
8G5
8TC
8UJ
95-
95.
95~
96X
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAPKM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBRH
ABBXA
ABDBE
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADHKG
ADIMF
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFDZB
AFEXP
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGQPQ
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHPBZ
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AYFIA
AZFZN
AZQEC
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ7
GQ8
GRRUI
GUQSH
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M2O
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P9S
PF0
PHGZT
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
ZGI
ZMTXR
ZOVNA
ZXP
~A9
~EX
AAYXX
ABFSG
ABRTQ
ACSTC
AEZWR
AFHIU
AFOHR
AHWEU
AIXLP
ATHPR
CITATION
PHGZM
PJZUB
PPXIY
CGR
CUY
CVF
ECM
EIF
NPM
7QO
8FD
FR3
K9.
NAPCQ
P64
7X8
5PM
ID FETCH-LOGICAL-c608t-3d738b76020947d9d7c65aeb0639498081929c9d72c28f7c72df1a73ef927a143
IEDL.DBID U2A
ISSN 0910-8327
1615-2573
IngestDate Thu Aug 21 18:33:46 EDT 2025
Fri Sep 05 00:18:09 EDT 2025
Wed Sep 03 00:17:12 EDT 2025
Mon Jul 21 05:47:04 EDT 2025
Tue Aug 05 12:12:23 EDT 2025
Thu Apr 24 23:09:40 EDT 2025
Thu Apr 10 07:46:46 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Aortic stenosis
Frailty
Surgical aortic valve replacement
Exercise capacity
Transcatheter aortic valve replacement
Language English
License This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c608t-3d738b76020947d9d7c65aeb0639498081929c9d72c28f7c72df1a73ef927a143
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC7897515
PMID 33615425
PQID 2548930340
PQPubID 36867
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7897515
proquest_miscellaneous_2492280955
proquest_journals_2548930340
pubmed_primary_33615425
crossref_citationtrail_10_1007_s00380_021_01793_3
crossref_primary_10_1007_s00380_021_01793_3
springer_journals_10_1007_s00380_021_01793_3
PublicationCentury 2000
PublicationDate 2021-08-01
PublicationDateYYYYMMDD 2021-08-01
PublicationDate_xml – month: 08
  year: 2021
  text: 2021-08-01
  day: 01
PublicationDecade 2020
PublicationPlace Tokyo
PublicationPlace_xml – name: Tokyo
– name: Japan
PublicationTitle Heart and vessels
PublicationTitleAbbrev Heart Vessels
PublicationTitleAlternate Heart Vessels
PublicationYear 2021
Publisher Springer Japan
Springer Nature B.V
Publisher_xml – name: Springer Japan
– name: Springer Nature B.V
References H Baumgartner (1793_CR15) 2017; 38
J Afilalo (1793_CR12) 2017; 70
R Boxer (1793_CR32) 2010; 16
I Fauchère (1793_CR36) 2014; 173
RS Boxer (1793_CR30) 2008; 17
AK Okoh (1793_CR28) 2017; 90
MB Leon (1793_CR4) 2016; 374
RA Nishimura (1793_CR16) 2017; 135
P Kleczynski (1793_CR11) 2017; 185
E Tamuleviciute-Prasciene (1793_CR38) 2018; 2018
Z Li (1793_CR9) 2019; 9
M Ogawa (1793_CR39) 2017; 6
I Waite (1793_CR33) 2017; 12
M Ogawa (1793_CR24) 2017; 12
N Yoshida (1793_CR21) 2017; 16
M Ogawa (1793_CR10) 2019
T Teramoto (1793_CR22) 2014; 21
RA Nishimura (1793_CR14) 2014; 129
CW Yancy (1793_CR20) 2013; 128
MB Leon (1793_CR3) 2010; 363
SM O’Brien (1793_CR19) 2018; 105
N Russo (1793_CR34) 2014; 21
S Eichler (1793_CR35) 2017; 24
C Bäck (1793_CR27) 2019; 53
LP Fried (1793_CR23) 2001; 56
SV Arnold (1793_CR6) 2014; 129
A Grimaldi (1793_CR5) 2013; 168
J Mehilli (1793_CR8) 2019; 35
SAM Nashef (1793_CR17) 2012; 41
RL Mehta (1793_CR26) 2007; 11
F Tarro Genta (1793_CR37) 2017; 18
R Ofori-Asenso (1793_CR40) 2019; 2
N Hiltrop (1793_CR7) 2016; 2
S Yamada (1793_CR31) 2015; 2
B Iung (1793_CR2) 2003; 24
TR Talbot (1793_CR25) 2005; 33
DM Shahian (1793_CR18) 2018; 105
CM Otto (1793_CR13) 2017; 69
BR Lindman (1793_CR1) 2016; 2
CP Huded (1793_CR29) 2016; 117
References_xml – volume: 168
  start-page: 281
  year: 2013
  ident: 1793_CR5
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2012.09.079
– volume: 135
  start-page: e1159
  year: 2017
  ident: 1793_CR16
  publication-title: Circulation
  doi: 10.1161/CIR.0000000000000503
– volume: 16
  start-page: 208
  year: 2010
  ident: 1793_CR32
  publication-title: Congest Heart Fail
  doi: 10.1111/j.1751-7133.2010.00151.x
– volume: 363
  start-page: 1597
  year: 2010
  ident: 1793_CR3
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1008232
– volume: 2
  start-page: 184
  year: 2016
  ident: 1793_CR7
  publication-title: Eur Heart J Qual Care Clin Outcomes
  doi: 10.1093/ehjqcco/qcw001
– volume: 105
  start-page: 1419
  year: 2018
  ident: 1793_CR19
  publication-title: Ann Thorac Surg
  doi: 10.1016/j.athoracsur.2018.03.003
– volume: 16
  start-page: 96
  year: 2017
  ident: 1793_CR21
  publication-title: Cardiovasc Diabetol
  doi: 10.1186/s12933-017-0577-8
– volume: 41
  start-page: 734
  year: 2012
  ident: 1793_CR17
  publication-title: Eur J Cardiothorac Surg
  doi: 10.1093/ejcts/ezs043
– volume: 24
  start-page: 257
  year: 2017
  ident: 1793_CR35
  publication-title: Eur J Prev Cardiol
  doi: 10.1177/2047487316679527
– volume: 12
  start-page: e0190359
  year: 2017
  ident: 1793_CR24
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0190359
– volume: 129
  start-page: 2682
  year: 2014
  ident: 1793_CR6
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.113.007477
– volume: 129
  start-page: e521
  year: 2014
  ident: 1793_CR14
  publication-title: Circulation
– volume: 53
  start-page: 348
  year: 2019
  ident: 1793_CR27
  publication-title: Scand Cardiovasc J
  doi: 10.1080/14017431.2019.1644366
– volume: 24
  start-page: 1231
  year: 2003
  ident: 1793_CR2
  publication-title: Eur Heart J
  doi: 10.1016/S0195-668X(03)00201-X
– volume: 35
  start-page: 199
  year: 2019
  ident: 1793_CR8
  publication-title: Can J Cardiol
  doi: 10.1016/j.cjca.2018.11.035
– volume: 21
  start-page: 296
  year: 2014
  ident: 1793_CR22
  publication-title: J Atheroscler Thromb
  doi: 10.5551/jat.19737
– year: 2019
  ident: 1793_CR10
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1016/j.jtcvs.2019.11.069
– volume: 38
  start-page: 2739
  year: 2017
  ident: 1793_CR15
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehx391
– volume: 18
  start-page: 114
  year: 2017
  ident: 1793_CR37
  publication-title: J Cardiovasc Med (Hagerstown)
  doi: 10.2459/JCM.0000000000000494
– volume: 11
  start-page: R31
  year: 2007
  ident: 1793_CR26
  publication-title: Crit Care
  doi: 10.1186/cc5713
– volume: 185
  start-page: 52
  year: 2017
  ident: 1793_CR11
  publication-title: Am Heart J
  doi: 10.1016/j.ahj.2016.12.005
– volume: 21
  start-page: 1341
  year: 2014
  ident: 1793_CR34
  publication-title: Eur J Prev Cardiol
  doi: 10.1177/2047487313494029
– volume: 69
  start-page: 1313
  year: 2017
  ident: 1793_CR13
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2016.12.006
– volume: 9
  start-page: e024163
  year: 2019
  ident: 1793_CR9
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2018-024163
– volume: 90
  start-page: 1000
  year: 2017
  ident: 1793_CR28
  publication-title: Catheter Cardiovasc Interv
  doi: 10.1002/ccd.27083
– volume: 374
  start-page: 1609
  year: 2016
  ident: 1793_CR4
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1514616
– volume: 12
  start-page: 91
  year: 2017
  ident: 1793_CR33
  publication-title: J Cardiothorac Surg
  doi: 10.1186/s13019-017-0655-8
– volume: 6
  start-page: 38
  year: 2017
  ident: 1793_CR39
  publication-title: Res in Cardiovasc Med
  doi: 10.4103/rcm.rcm_22_17
– volume: 2
  start-page: 16006
  year: 2016
  ident: 1793_CR1
  publication-title: Nat Rev Dis Primers
  doi: 10.1038/nrdp.2016.6
– volume: 128
  start-page: e240
  year: 2013
  ident: 1793_CR20
  publication-title: Circulation
– volume: 70
  start-page: 689
  year: 2017
  ident: 1793_CR12
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2017.06.024
– volume: 117
  start-page: 1966
  year: 2016
  ident: 1793_CR29
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2016.03.044
– volume: 105
  start-page: 1411
  year: 2018
  ident: 1793_CR18
  publication-title: Ann Thorac Surg
  doi: 10.1016/j.athoracsur.2018.03.002
– volume: 173
  start-page: 564
  year: 2014
  ident: 1793_CR36
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2014.03.121
– volume: 2
  start-page: e198398
  year: 2019
  ident: 1793_CR40
  publication-title: JAMA Netw Open
  doi: 10.1001/jamanetworkopen.2019.8398
– volume: 56
  start-page: M146
  issue: 3
  year: 2001
  ident: 1793_CR23
  publication-title: J Gerontol A Biol Sci Med Sci
  doi: 10.1093/gerona/56.3.M146
– volume: 2018
  start-page: 9849475
  year: 2018
  ident: 1793_CR38
  publication-title: Biomed Res Int
  doi: 10.1155/2018/9849475
– volume: 17
  start-page: 7
  year: 2008
  ident: 1793_CR30
  publication-title: Am J Geriatr Cardiol
  doi: 10.1111/j.1076-7460.2007.06457.x
– volume: 2
  start-page: 168
  year: 2015
  ident: 1793_CR31
  publication-title: ESC Heart Fail
  doi: 10.1002/ehf2.12052
– volume: 33
  start-page: 353
  issue: 6
  year: 2005
  ident: 1793_CR25
  publication-title: Am J Infect Control
  doi: 10.1016/j.ajic.2004.10.008
SSID ssj0015919
Score 2.3129435
Snippet Assessment of frailty is important for risk stratification among the elderly with severe aortic stenosis (AS) when considering interventions such as surgical...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1234
SubjectTerms Aged
Aged, 80 and over
Aorta
Aortic stenosis
Aortic valve
Aortic Valve Stenosis - diagnosis
Aortic Valve Stenosis - surgery
Biomedical Engineering and Bioengineering
Cardiac Surgery
Cardiology
Complications
Exercise Tolerance
Frailty
Frailty - complications
Frailty - diagnosis
Heart Valve Prosthesis Implantation
Heart valves
Humans
Medicine
Medicine & Public Health
Original
Original Article
Patient Discharge
Postoperative Complications - epidemiology
Recovery of function
Retrospective Studies
Stenosis
Therapeutic applications
Transcatheter Aortic Valve Replacement - adverse effects
Vascular Surgery
Title Preoperative frailty affects postoperative complications, exercise capacity, and home discharge rates after surgical and transcatheter aortic valve replacement
URI https://link.springer.com/article/10.1007/s00380-021-01793-3
https://www.ncbi.nlm.nih.gov/pubmed/33615425
https://www.proquest.com/docview/2548930340
https://www.proquest.com/docview/2492280955
https://pubmed.ncbi.nlm.nih.gov/PMC7897515
Volume 36
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEB7aBEovpU3axmkaVCi9dA1eWw_ruCnZhJaEHrqQnowsyySQ2IvXe8iv6V_NjPwo2zSBnAzW-MWMpE-eT98AfJaFza0oeSilESF32oZpgkBuKo1SIi8kLymje3YuTxf8-4W46DeFrQa2-5CS9CP1uNmNklhRSJQCH1Vh8hy2Ba7dici3iGdj7kDoaaewhyMMxqvqt8r8_x6b09E9jHmfKvlPvtRPQ_PX8KrHj2zWOfwNPHPVDuzOKlw739yyL8wzOv2v8h14cdYnznfhz8_G1UvXyXyzsjFX1-0tMx2Zgy1JXWNs3WCZT9hQlIlZnFctgvYJM1XBLusbx2hPL0ktOUaKEyvmK46z1brx46m3a2ky9OKw1GRqenGG4Y0PapxnhNH_ybewmB__-nYa9rUZQiujtA2TQiVpriSiTc1VoQtlpTAuJ8TDNZXzQNxl8XRs47RUVsVFOTUqcaWOlUGQ9g62qrpye8BSWoPmHEOaO055yFy4qBAqcrFDNJEHMB1clNleuJzqZ1xno-Syd2uGbs28W7MkgK_jNctOtuNR64PB81nfhVcZrpwRy0UJjwL4NDZj56OMiqlcvUYbrklOSAsRwPsuUMbHJQmCRRwRA1AbITQakLD3Zkt1dekFvlWqFeLMACZDsP19rYe_Yv9p5h_gZew7ApEZD2CrbdbuIwKsNj-E7dn86Oicjie_fxwf-v51B0ZcIlA
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB7BVgIuPFoegQJGQlzYVNnEjpPjCrUstFtx6ErlFNmOo1a0ySqbPZQ_w19lxnmgbQGp13gSx_J4_I1n_A3A-zg32oiC-3GshM9tavwkQiA3iZWUQucxLyiiOz-OZwv-9VScdpfCVn22ex-SdJZ6uOxGQazAp5QCp1V-dBe2OPrgfARb08_fD_eH6IFIJy3HHtoY1FjZXZb5-1c2N6QbKPNmsuS1iKnbiA4ewaIfQpt_8mNv3eg98_Mau-Ntx_gYHnbIlE1bVXoCd2y5DTvTEr3yyyv2gblcUXcIvw335l1Ifgd-fatttbQtgTgranV-0Vwx1aaJsCXxdgytG_nrY9aXe2IGd2yD7sCYqTJnZ9WlZXRbmEicLCMuixVztczZal07S-3kGtpmHe0sNamKfpzhwsGOautyzejk8yksDvZPPs38ruqDb-Igafwol1GiZYw4NuUyT3NpYqGsJizFUyoUgojO4OPQhEkhjQzzYqJkZIs0lArh3zMYlVVpXwBLyLvVHBcLt5winFrYIBcysKFFnKI9mPRTn5mOEp0qc1xkA5mzm5AMJyRzE5JFHnwc3lm2hCD_ld7tNSrrjMMqQ58cUWIQ8cCDd0MzLmuK1ajSVmuU4SkRFaVCePC8VcChuyhCGIq21gO5oZqDAFGGb7aU52eOOlwmqUQE68G4178_v_XvUby8nfhbuD87mR9lR1-OD1_Bg9CpM6VM7sKoqdf2NcK4Rr_pVu1v_NA_IA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7BVqq48GihBAoYCXFh02YTO06OK-hSKK16oFI5RbbjqBVtsspmD-XP8FeZcR6wLSAhrvHkYfmz_Tkz8w3Aqzg32oiC-3GshM9tavwkQiI3iZWUQucxL8ije3gU75_wj6fi9Jcsfhft3rsk25wGUmkqm915XuwOiW_k0Ap8Ci9wCPOj27DGSZx9BGvT918O9gZPgkgnrd4erjeIXtklzvz-Kaub0w3GeTNw8pr31G1Ks3ug-u60sShfd5aN3jHfrik9_k9_78PdjrGyaQuxB3DLlhuwOS3xtH55xV4zF0Pqfs5vwPph56rfhO_Hta3mthUWZ0Wtzi-aK6ba8BE2Jz2PoXUlrn3M-jJQzOBObvCYMGaqzNlZdWkZZRGTuJNlpHGxYK7GOVssa7eCO7uGtl8nR0tNqqIPZzih8EW1dTFo9Ef0IZzM9j6_3fe7ahC-iYOk8aNcRomWMfLblMs8zaWJhbKaOBZPqYAIMj2Dl0MTJoU0MsyLiZKRLdJQKqSFj2BUVqV9DCyhU6_mOIm45eT51MIGuZCBDS3yF-3BpIdBZjqpdKrYcZENIs9uQDIckMwNSBZ58Ga4Z94KhfzVertHV9YtGosMz-rIHoOIBx68HJpxupMPR5W2WqINT0nAKBXCg60WjMProgjpKa7BHsgVmA4GJCW-2lKenzlJcZmkEpmtB-Meiz8_68-9ePJv5i9g_fjdLPv04ejgKdwJHZopknIbRk29tM-Q3TX6eTeBfwDMI0gE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Preoperative+frailty+affects+postoperative+complications%2C+exercise+capacity%2C+and+home+discharge+rates+after+surgical+and+transcatheter+aortic+valve+replacement&rft.jtitle=Heart+and+vessels&rft.au=Komaki%2C+Kodai&rft.au=Yoshida%2C+Naofumi&rft.au=Satomi-Kobayashi%2C+Seimi&rft.au=Tsuboi%2C+Yasunori&rft.date=2021-08-01&rft.issn=0910-8327&rft.eissn=1615-2573&rft.volume=36&rft.issue=8&rft.spage=1234&rft.epage=1245&rft_id=info:doi/10.1007%2Fs00380-021-01793-3&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00380_021_01793_3
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0910-8327&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0910-8327&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0910-8327&client=summon